We apply a flexible and analytics-driven approach across pre-diligence investment screening, action- and impact-oriented portfolio development, and exit strategy. Our global, cross-industry and functional scale and scope in medtech, health systems, and therapeutics bring distinctive insights to create the greatest value.
Rapid diligence services: Our flexible and analytics-driven approach to due diligence that draws on our deep industry expertise to offer a wide range of potential configurations—from targeted analysis to fully integrated due diligence
Recovery and transformation services: A unit that focuses on sustained performance improvement and high-impact turnarounds for especially challenging cases, such as distressed companies and underperforming business units, across all industries and geographies Learn more
McKinsey Implementation: A group of specialist teams that works side by side with portfolio companies and offers tailored support to help accelerate the execution of recommendations and improvement plans for measurable bottom-line results Learn more
Pricing for growth: A process by which our pricing experts identify initiatives for portfolio companies to drive near-term earnings before interest and taxes:
- To capture full pricing potential, we run multiquarter-long pricing transformations that deliver 2 to 3 percent returns on sales within 12 months of implementation.
- We leverage our knowledge of hospital purchasing, effective competitive strategies, and driving behavior change within the sales force to help clients achieve both top- and bottom-line growth.